DNA Vaccines May Offer Hope In MS
Authors from the VA North Texas Health Care System Neurology Section and the Department of Neurology at the University of Texas Southwestern Medical Center at Dallas have highlighted the potential benefits for DNA-based vaccine administration in patients with multiple sclerosis (MS).

---

DNA vaccines may offer hope in multiple sclerosis
News-Medical-Net Thu, 24 Apr 2008 6:14 PM PDT
Authors from the VA North Texas Health Care System Neurology Section and the Department of Neurology at the University of Texas Southwestern Medical Center at Dallas have highlighted the potential benefits for DNA-based vaccine administration in patients with multiple sclerosis (MS).
Accelerating Biomarker Discovery And Disease Research With Tecan's Automated Hybridization Stations
BioresearchOnline Fri, 25 Apr 2008 6:24 AM PDT
Protagen AG, a provider of products, services and software solutions for protein research based in Dortmund, Germany, relies on two Tecan HS 4800 Pro Hybridization Stations for automated processing of its UNIchip protein arrays for antibody characterization, and for discovery of biomarkers relevant to diseases such as multiple sclerosis, rheumatoid arthritis and cancer indications

DNA vaccines may offer hope in multiple sclerosis
News-Medical.net - Sydney,Australia
The authors highlight a recent safety trial with BHT-2009 - the first trial with a DNA vaccine for an autoimmune disease in human patients - which showed it ...
See all stories on this topic

FSG Media Release: DNA Vaccines may offer hope in MS
PharmaLive.com (press release) - Newtown,PA,USA
The authors, Drs Olaf Stüve, Petra Cravens and Todd Eager, draw attention to recent clinical studies involving BHT-3009, a DNA vaccine encoding full-length ...
See all stories on this topic

Coronary victim ‘100%’ after stem cell trial
The Herald - Glasgow,Scotland,UK
Earlier this week, The Herald revealed the effects of multiple sclerosis could be reversed within 15 years using stem-cell treatment. ...
See all stories on this topic

Genentech's Rituxan Fails in MS Trial
FDA news (subscription) - Falls Church,VA,USA
... multicenter study was designed to evaluate the efficacy, safety and tolerability of four courses of Rituxan (rituximab) in 439 patients with PPMS. ...
See all stories on this topic

Breaking Ground In Discovering How Neurons Generate Movement
When the eye tracks a bird's flight across the sky, the visual experience is normally smooth, without interruption. But underlying this behavior is a complex coordination of neurons that has remained mysterious to scientists.

---

Critical New Information Added To Nursing Home Compare Web Site
Medicaid beneficiaries and families searching for top quality long-term care services can find critical new information added to the Centers for Medicare & Medicaid Services' (CMS) Web site "Nursing Home Compare.